Drs Smith and Helfand look ahead and provide their thoughts on future directions in the treatment of patients with prostate cancer.
Study finds disparities in management of mCSPC
April 17th 2024“These findings suggest that guideline recommended treatment intensification remains low for patients with mCSPC in both Medicare and the Veterans Health Administration, but especially for Black patients,” says Daniel J. George, MD.